ALDEA Pharmaceuticals develops small-molecule modulators of the ALDH family for the treatment of toxic aldehyde-related diseases.
Business Model:
Revenue: $0
Employees: 201-500
Address:
City: Redwood City
State: California
Zip:
Country: United States
ALDEA Pharmaceuticals is developing small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) family, to treat toxic aldehyde-related diseases. This proprietary technology represents new product opportunities to address novel targets across multiple therapeutic areas. For example, an ALDH activator compound enhances the detoxification of acetaldehyde in the alcohol metabolism pathway, to treat acute symptoms and to reduce long-term tissue damage and cancer risk. The company was founded in 2011 and headquartered in Redwood City, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Venture Round | 1 | $2M |
Canaan Partners Canaan Partners |
11/2013 | Series A | 1 | $11.5M |
Correlation Ventures Correlation Ventures |
5/2012 | Debt Financing | 2 | $4.5M |
Canaan Partners Correlation Ventures Canaan Partners Correlation Ventures |
8/2014 | Series B | 4 | $24M |
Canaan Partners Correlation Ventures RMI Partners WuXi AppTec Canaan Partners Correlation Ventures RMI Partners WuXi AppTec |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|